Abstract:N-(3-fluoro-4-((6-methoxy-7-(3-(4-methylpiperazin-1-yl) propoxy) quinolin-4-yl) oxy) phenyl)-1-(2-fluorophenyl)-4-methyl-5-oxo-4,5-dihydro-1 H-1,2,4-triazole-3-carboxamide (LJC-116) is a kind of new Type Ⅱ compounds,c-Met kinase inhibitors with 4-phenoxy quinolone.In vitro experiments showed that they have an excellent anti-tumor activity.In this paper,the in vitro molecular binding interaction between LJC-116 and human serum albumin(HSA) was further inves tigated by various methods,such as fluorescence spectrometry,synchronous fluorescence spectrometry,fluorescence probe experiments,three-dimensional(3-D) fluorescence spectrometry,ultraviolet-visible (UV-Vis) absorption spectroscopy and molecular docking.It was found that the intrinsic fluo rescence of HSA could be quenched by LJC-116 through a static quenching process.The static quenching process was also proved by 3-D fluorescence spectrometry and ultraviolet-visible absorption spectroscopy.The apparent binding constants between LJC-116 and HSA at 288,299,310 K were estimated to be in the order of 104 L · mo1-1,which indicated the binding between LJC-116 and HSA was moderate.The thermodynamic parameters △H°,△G° and △S° were calculated,in which the negative △G° suggested that the binding of LJC-116 to HSA was spontaneous.Moreover,the positive △S° and negative △H° revealed that hydrophobic interaction and hydrogen bonds were the major forces to stabilize the protein-LJC-116 (1 ∶ 1) complex.Under the experimental conditions,the overlapping integral J =7.169 7 × 10-15 cm3 · L · mol-1,R =1.28 nm,r =1.69 nm,E =15.6％ were obtained.It indicated a high probability of energy transfer from HSA to LJC-116.Probe agent ibuprofen and warfarin were added in system of HSA-LJC-116,it showed that the primary binding site of LJC-116 was located at site Ⅰ (subdomain Ⅱ A) of HSA.The slight redshift of fluorescence(0.3 nm),synchronous fluorescence(0.4 nm) and 3-D fluorescence spectra(2 nm) all demonstrated that the polarity of microenvironment for amino acid residues in HSA increased and the hydrophobic property decreased.Finally,the forces deduced from the thermodynamic calculation,and the conformational changes of HSA were validated by the molecular docking.The interaction mechanism of HSA and LJC-116 was comprehensively expatiated at a molecular level in this paper,and some useful information for the transport of Type Ⅱ c-met kinase inhibitors in vivo was provided.

Study on the Interaction of Two Quinazoline Derivatives As Novel PI3K/mTOR Dual Inhibitors and Anticancer Agents to Human Serum Albumin Utilizing Spectroscopy and Docking

Investigation on In Vitro Binding of a New Anti-tumor Compound and Human Serum Albumin by Spectroscopic Methods and Molecular Docking

Pharmacokinetics and Tissue Distribution Study of Two Novel Quinazoline PI3K/mTOR Dual-Inhibitors, Potential Anticancer Agents.

Investigation of Binary and Ternary Systems of Human Serum Albumin with Oxyresveratrol/piceatannol And/or Mitoxantrone by Multipectroscopy, Molecular Docking and Cytotoxicity Evaluation

Comparative Interactions of Dihydroquinazolin Derivatives with Human Serum Albumin Observed Via Multiple Spectroscopy

Uncovering the Molecular and Physiological Processes of Anticancer Leads Binding Human Serum Albumin: A Physical Insight into Drug Efficacy

Studies on the Binding of Curcumin and Glycyrrhetinic Acid to Human Serum Albumin by Multi-Spectroscopic Methods and Molecular Docking Approaches

Multiple Spectroscopic, Docking and Cytotoxic Study of a Synthesized 2,2′ Bipyridin Phenyl Isopentylglycin Pt(II) Nitrate Complex: Human Serum Albumin and Breast Cancer Cell Line of MDA-MB231 as Targets

Molecular Interaction Study of Flavonoid Derivative 3d with Human Serum Albumin Using Multispectroscopic and Molecular Modeling Approach

Spectroscopic Methodologies and Molecular Docking Studies on the Interaction of the Soluble Guanylate Cyclase Stimulator Riociguat with Human Serum Albumin

Probing the intermolecular interactions into serum albumin and anthraquinone systems: a spectroscopic and docking approach

Discovery of a Series of N-(5-(quinolin-6-yl)pyridin-3-yl)benzenesulfonamides As PI3K/mTOR Dual Inhibitors

Interaction of Human Serum Albumin with 10-Hydroxycamptothecin: Spectroscopic and Molecular Modeling Studies

Probing the Anticancer-Drug-binding-induced Microenvironment Alterations in Subdomain IIA of Human Serum Albumin.

Mechanism Understanding of PIKfyve Inhibitor YM201636 with Human Serum Albumin: Insights from Molecular Modeling and Multiple Spectroscopic Techniques

In Vitro Characterization for Human Serum Albumin Binding Sorafenib, A Multi Kinase Inhibitor: Spectroscopic Study

Spectroscopic investigation of the anticancer alkaloid piperlongumine binding to human serum albumin from the viewpoint of drug delivery.

Investigations on the Interactions Between Naphthalimide-Based Anti-Tumor Drugs and Human Serum Albumin by Spectroscopic and Molecular Modeling Methods

Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives As Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases.

Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach

Spectroscopic and in silico characterization of the interaction between synthetic 2-Substituted-Naphtho-1,4-quinones and human serum albumin